Interpatient variation of clinical responses among acute lymphoblastic leukaemia (all) patients treated with 6-mercatopurine (6-MP): a pharmacogenomics - metabolomics perspective / Wan Rosalina Wan Rosli
Leukaemia chemotherapy had advanced considerably, enabling higher rates of survival and cure. This success is largely attributable to optimization of the use of chemotherapeutic agents such as 6-mercaptopurine (6-MP). How ever challenges still remain in striking a delicate balance between therapeuti...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | English |
| منشور في: |
2011
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ir.uitm.edu.my/id/eprint/39782/1/39782.pdf |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|